Coptisine
CAS: 3486-66-6
Ref. TM-T5S0053
1mg | 45,00 € | ||
5mg | 89,00 € | ||
10mg | 135,00 € | ||
25mg | 246,00 € | ||
50mg | 444,00 € | ||
100mg | 648,00 € | ||
1ml*10 (DMSO) | 104,00 € |
Información del producto
- Coptisin
- 6,7-Dihydrobis[1,3]benzodioxolo[5,6-a:4′,5′-g]quinolizinium
- Alkaloid A, from Coptisgroenlandica
- Alkaloid A, fromCoptis groenlandica
- Berbinium,7,8,13,13a-tetradehydro-2,3:9,10-bis(methylenedioxy)-
- Bis[1,3]benzodioxolo[5,6-a:4',5'-g]quinolizinium,6,7-dihydro-
- Bis[1,3]benzodioxolo[5,6-a:4′,5′-g]quinolizinium, 6,7-dihydro-
- Yhl Ii
1. Coptisine (Coptisin) treatment increases cell viability based on its reversal effect on the enhanced activity of Indoleamine 2, 3-dioxygenase . 2. Coptisine treats myocardial I/R likely through suppressing myocardial apoptosis and inflammation by inhibiting the Rho/ROCK pathway. 3. Coptisine is a potential anti-osteosarcoma drug candidate, via exerting a strong anti-osteosarcoma effect with very low toxicity . 4. Coptisine with a high dosage could inhibit cholesterol synthesis via suppressing the HMGCR expression and promoting the use and excretion of cholesterol via up-regulating LDLR and CYP7A1 expression. 5. Coptisine suppresses adhesion, migration and invasion of MDA-MB-231 breast cancer cells in vitro, the down-regulation of MMP-9 in combination with the increase of TIMP-1 possibly contributing to the anti-metastatic function for breast cancer.
Propiedades químicas
Consulta técnica sobre: TM-T5S0053 Coptisine
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.